Discover the price reduction of ENFINIA™ DNA products by 25%, improving access to high-quality DNA for researchers.

Price drop reflects efficiency gains from Co.’s cell-free cloning tech & new facility, where automation & ML have increased ...

coli expression system. It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the ...

Conjugation is a form of horizontal gene transfer that allows the exchange of genetic material between two organisms or cells ...

INOVIO (NASDAQ: INO) has announced notable interim findings from a Phase 1 clinical trial testing DNA-encoded monoclonal ...

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the ...

(NASDAQ: IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapy and evaluating an adaptation of the platform’s potential as a next-generation vaccine, today ...

This article discusses the mechanisms of bacterial transduction and how scientists can utilize it to manipulate bacterial ...

Chinese scientists have developed a gene-editing system for plants that draws on material from deadly viruses such as dengue fever to improve safety and efficiency. Commonly used gene-editing ...